JP2003521900A - 前駆細胞保存因子、並びに関連する方法および産物 - Google Patents

前駆細胞保存因子、並びに関連する方法および産物

Info

Publication number
JP2003521900A
JP2003521900A JP2001550379A JP2001550379A JP2003521900A JP 2003521900 A JP2003521900 A JP 2003521900A JP 2001550379 A JP2001550379 A JP 2001550379A JP 2001550379 A JP2001550379 A JP 2001550379A JP 2003521900 A JP2003521900 A JP 2003521900A
Authority
JP
Japan
Prior art keywords
cells
fril
progenitor
cell
family member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001550379A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003521900A5 (enExample
Inventor
コルッチ，エンメ・ガブリエラ
クリスピールズ，マーテン・ジェイ
ムーア，ジェフリー・ジー
Original Assignee
ファイロジックス・エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファイロジックス・エルエルシー filed Critical ファイロジックス・エルエルシー
Publication of JP2003521900A publication Critical patent/JP2003521900A/ja
Publication of JP2003521900A5 publication Critical patent/JP2003521900A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
JP2001550379A 1999-12-30 1999-12-30 前駆細胞保存因子、並びに関連する方法および産物 Pending JP2003521900A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/031307 WO2001049851A1 (en) 1999-12-30 1999-12-30 Progenitor cell preservation factors and related methods and products

Publications (2)

Publication Number Publication Date
JP2003521900A true JP2003521900A (ja) 2003-07-22
JP2003521900A5 JP2003521900A5 (enExample) 2007-03-22

Family

ID=22274423

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001550379A Pending JP2003521900A (ja) 1999-12-30 1999-12-30 前駆細胞保存因子、並びに関連する方法および産物

Country Status (10)

Country Link
EP (1) EP1246919B1 (enExample)
JP (1) JP2003521900A (enExample)
CN (1) CN1406280A (enExample)
AT (1) ATE302848T1 (enExample)
AU (1) AU784361C (enExample)
CA (1) CA2395625A1 (enExample)
DE (1) DE69926920T2 (enExample)
ES (1) ES2249058T3 (enExample)
HK (1) HK1050027B (enExample)
WO (1) WO2001049851A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007513879A (ja) * 2003-11-12 2007-05-31 モーニングサイド・ベンチャー・インベストメンツ・リミテッド Ｂ細胞リンパ腫及びその他の癌を治療するための方法及び組成物
JP2015029503A (ja) * 2013-08-06 2015-02-16 日本メナード化粧品株式会社 幹細胞の未分化状態維持剤及び増殖促進剤
US11083190B2 (en) 2007-06-29 2021-08-10 Makoto Funaki Soft gel systems in modulating stem cell development

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132017A1 (en) 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
JP4394350B2 (ja) 2001-01-09 2010-01-06 ベイラー リサーチ インスティテュート 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ
WO2002067973A1 (en) * 2001-02-27 2002-09-06 Phylogix Llc Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues
WO2006110577A2 (en) * 2005-04-08 2006-10-19 Morningside Venture Investments Limited Use of fril proteins for reducing the production of pro-inflammatory cytokines
EP2108043A4 (en) 2007-01-18 2010-04-21 Suomen Punainen Risti Veripalv NEW METHODS AND REAGENTS FOR THE PRODUCTION OF CELLS
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
JP7393945B2 (ja) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド 細胞増殖
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP4314244B1 (en) 2021-03-23 2025-07-23 Terumo BCT, Inc. Cell capture and expansion
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
CN114262683B (zh) * 2022-03-01 2022-06-17 中国科学院动物研究所 一种表达vegfr3 d2多肽的细菌制剂及其构建方法和应用
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998025457A1 (en) * 1996-12-09 1998-06-18 Imclone Systems Incorporated Composition and method for preserving progenitor cells
WO1998059038A1 (en) * 1997-06-24 1998-12-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455678B1 (en) * 1996-04-26 2002-09-24 Amcell Corporation Human hematopoietic stem and progenitor cell antigen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998025457A1 (en) * 1996-12-09 1998-06-18 Imclone Systems Incorporated Composition and method for preserving progenitor cells
WO1998059038A1 (en) * 1997-06-24 1998-12-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007513879A (ja) * 2003-11-12 2007-05-31 モーニングサイド・ベンチャー・インベストメンツ・リミテッド Ｂ細胞リンパ腫及びその他の癌を治療するための方法及び組成物
US11083190B2 (en) 2007-06-29 2021-08-10 Makoto Funaki Soft gel systems in modulating stem cell development
JP2015029503A (ja) * 2013-08-06 2015-02-16 日本メナード化粧品株式会社 幹細胞の未分化状態維持剤及び増殖促進剤

Also Published As

Publication number Publication date
HK1050027B (en) 2006-04-13
EP1246919B1 (en) 2005-08-24
HK1050027A1 (en) 2003-06-06
WO2001049851A1 (en) 2001-07-12
AU784361B2 (en) 2006-03-16
CN1406280A (zh) 2003-03-26
DE69926920T2 (de) 2006-06-29
DE69926920D1 (de) 2005-09-29
EP1246919A1 (en) 2002-10-09
AU784361C (en) 2007-03-15
ES2249058T3 (es) 2006-03-16
ATE302848T1 (de) 2005-09-15
CA2395625A1 (en) 2001-07-12
AU2401400A (en) 2001-07-16

Similar Documents

Publication Publication Date Title
AU784361B2 (en) Progenitor cell preservation factors and related methods and products
EP1017789B1 (en) Nucleic acid encoding a lectin-derived progenitor cell preservation factor
US8071377B2 (en) Methods for immortalizing cells
EA020508B1 (ru) ВЫДЕЛЕННЫЕ АНТИТЕЛА К Sp35 И ИХ ПРИМЕНЕНИЕ
WO1997019172A1 (en) Differentiation-suppressive polypeptide
JP2003530124A (ja) 新規幹細胞成長因子様ポリペプチドおよびポリヌクレオチドに関する方法および物質
US20190060366A1 (en) Highly engraftable hematopoietic stem cells
WO1998002458A1 (en) Differentiation inhibitor
JP2009509540A (ja) 幹細胞におけるＴｏｌｌ様受容体の調節
US6991794B1 (en) Progenitor cell preservation factors and methods for and products of their use
JPH10508756A (ja) 造血タンパク質を用いて赤血球形成を刺激する方法
JPH10511681A (ja) 精製されたトロンボポエチン及びその製造方法
WO1999055864A1 (fr) Nouveau polypeptide, adnc le codant et son utilisation
EP1584686A1 (en) Progenitor cell preservation factors and related methods and products
CN114174328B (zh) Gaba激动剂和拮抗剂影响造血干细胞和巨核系祖细胞的分化
HK1084413A (en) Progenitor cell preservation factors and related methods and products
JP2000515726A (ja) 分泌蛋白をコードする成人ｐｂｍｃ由来のポリヌクレオチド
JP2008521753A (ja) 副甲状腺ホルモン受容体の活性化並びに幹細胞及び前駆細胞の増殖
WO2002070679A2 (en) Peptide fragments, derived from human telomerase reverse transcriptase
CA2340465A1 (en) Genes that regulate hematopoietic blood forming stem cells and uses thereof
JP2002510312A (ja) 分泌蛋白
DE DK et al. NUKLEINSÄURE, WELCHE EINEN VON LEKTIN ABSTAMMENDEN FAKTOR ZUR PRÄSERVIERUNG VON PROGENITORZELLEN KODIERT ACIDE NUCLEIQUE CODANT UN FACTEUR DE CONSERVATION DE CELLULES PROGENITRICES DERIVE DE LA LECTINE
Sharkis STEM CELL PLASTICITY: WILL IT BE USEFUL TO REPAIR INJURY?
JP2003518925A (ja) Ｔ細胞活性化に関与する新規遺伝子ｔｚａｐ７／ａ、ｔｚａｐ７／ｂ、およびｔｚａｐ７、ならびにその使用
JP2002512503A (ja) 分泌蛋白およびそれらをコードするポリヌクレオチド

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20041006

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20041006

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070104

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070104

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091208

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100427